Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
 

Learn about the flu shot, COVID-19 vaccine, and our masking policy »

Stanford Health Care

IgA nephropathy: toward more specific diagnosis (and rescue of snails) KIDNEY INTERNATIONAL Floege, J. 2018; 93 (3): 542–44

Abstract

The diagnosis of IgA nephropathy relies on the histologic demonstration of glomerular mesangial IgA deposits. However, only a very small fraction of IgA, namely, galactose-deficient IgA1, seems to induce the disease. So far, this type of IgA could only be detected using mass spectrometry or lectins, which are relatively difficult to standardize. A novel monoclonal antibody, KM55, specifically recognizing galactose-deficient IgA1, may now change this.

View details for DOI 10.1016/j.kint.2017.10.028

View details for Web of Science ID 000425713400005

View details for PubMedID 29475546